Concomitant use of Dopamine agonist Bromocriptine with Glimepride Improves Insulin Sensitivity in Type II Diabetic Patients

Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2016, Vol 11, Issue 6

Abstract

Type -2 diabetes mellitus (T2DM) is a complex syndrome originated by a multifactorial pathogenesis. Restoration of a normal glycaemia is very difficult and requires a multiple medication with different mechanismsof action that can be used in combination to produce an additive effect. Bromocriptine (BC) is a sympatholytic D2 dopamine agonist which can be used as an anti-diabetic agent with a novel mechanism of action in combination with a currently used drug glimepiride. Objective: The aim of this work is to study theeffect ofaddition of BC toglimepiride inuncontrolled type 2 diabetic patients treated with glimepiride. Design: we collect the type 2 diabetic patients which treated with glimepiride and not achieved a glycemic control and compare their results with other glimepride-treated group with combination with 1.25 mg BC once daily. Three groups divided randomly: the first group take glimepiride 3mg once daily, the second group takes glimepiride 3 mg once daily plus 1.25 mg of BC once daily, the third group is the control group. A control group comprising healthy, normal glycemic individuals was used for comparison.The effect of BC on glucose homeostasis parameters (e.g. blood glucose level, serum insulin, insulin resistance using the homeostasis model assessment), lipid profile, and dopamine and adiponectin levels are investigated.

Authors and Affiliations

Abla M . Ebeid1, Rania M. Khalil2

Keywords

Related Articles

Antibacterial and Antifungal Actuvity of Organic Solvent Extracts Of Knoxia Corymbosa

Objective: In this study the potency of antibacterial activities of crude organic solvent extracts ethyl acetate, dichloromethane, and methanol extracts of Knoxia corymbosa were tested on bacterial pathogens Escherichia...

Allellopathic potential of invasive Psidium guajava L., against selected native tree species in Kakamega Tropical Forest, Western Kenya.

Studies have previously attributed P. guajava invasiveness to its aggressive regeneration and profuse seeding. This study, however verified that its allellopathic influence on native plant species also plays an important...

Evaluation of the Anticonvulsant Activity of the Aqueous Extract of Crinum Scillifolium Bulbs (Amaryllidaceae) In Experimental Animals

Crinum species known today are generally used in traditional medicine to treat a variety of diseases such as tumors, fever, malaria, febrile convulsions. The present study was aimed to evaluate the anticonvulsant propert...

Evaluation of Calcium Regulating Hormones in a Sample of Patients with Thyroid Disorders

The present study aims to evaluate the levels of calcium regulating hormones in patients with thyroid disorders. Ninety Iraqi subjects with age range (20-55) years were divided into three groups; first group included 30...

Gut Microbiota: The Missing Link in Obesity Induced Nonalcoholic Liver Disease

Background and objective: Recent research has elucidated a close association between intestinal microbiota, obesity, insulin resistance and nonalcoholic hepatic injury. Various studies have also indicated an increase in...

Download PDF file
  • EP ID EP386672
  • DOI 10.9790/3008-1106011319 .
  • Views 69
  • Downloads 0

How To Cite

Abla M . Ebeid1, Rania M. Khalil2 (2016). Concomitant use of Dopamine agonist Bromocriptine with Glimepride Improves Insulin Sensitivity in Type II Diabetic Patients. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), 11(6), 13-19. https://europub.co.uk/articles/-A-386672